top of page

Journal Club

2026.10.20

Somatic epimutations cap genetic determinism in the human diploid chromatin epigenome

Cell

​

2026.10.13

Copper ion-induced MYH9 polymerization executes cuproptosis

Cell

​

 

2026.09.29

Iron-addicted colorectal cancers exploit heme-complex II axis to resist oxidative cell death

Cell Metabolism

​

 

2026.09.22

Hypertranscription caused by p53 deficiency triggers nucleotide insufficiency that induces replication stress and genomic instability

Molecular Cell

​

 

2026.09.08

IGF2BP1 phosphorylation in the disordered linkers regulates ribonucleoprotein condensate formation and RNA metabolism

Nature Communications

​

 

2026.09.01

Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations

Nature Genetics

​

 

2026.08.25

ZFP36L2 orchestrates stress-adaptive plasticity in regeneration and cancer

Nature

​

 

2026.08.18

mRNA 3′ UTRs chaperone intrinsically disordered regions to control protein activity

Cell

​

 

2026.08.11

Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance

Cell

​

 

2026.08.04

Targeting cancer-specific mutations with RNA-triggered chromatin shredding

Nature

​

 

2026.07.28

RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity

Molecular Cell

​

 

2026.07.21

m6A modification suppresses innate antitumour immunity in colorectal cancer by limiting alu-derived dsRNA accumulation

Nature Communications

​

 

2026.07.14

p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis

Molecular Cell

​

 

2026.06.30

METTL3-mediated m6A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca2+ signaling

Molecular Cancer

​

 

2026.06.23

USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1- mediated phosphorylation

Nature Communications

​

 

2026.06.16

Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer

Cell Death & Disease

​

 

2026.06.09

Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation

Genome Biology

​

 

2026.06.02

Profiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing

Nature Methods

​

 

2026.05.19

HSF1 and YTHDC1 enhance DNA repair under heat stress by promoting repair-associated gene expression

Nucleic Acids Research

​

 

2026.05.12

BE screen reveals METTL3 S2 dephosphorylation sensitizes gastric cancer cells to oxaliplatin by interfering METTL3-eIF3H interaction

Science Advances

​

 

2026.04.21

Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R-Loop Accumulation and DNA Repair Deficiencies

Advanced Science

​

 

2026.04.14

The METTL3-YTHDC1 axis mediates architectural RNA m6A modification to modulate the integrity of chromatin TADs in MLLr+AML genome

Molecular Cancer

​

 

2026.04.07

RNA polymerase II partitioning is a shared feature of diverse oncofusion condensates

Cell

​

 

2026.03.30

Cancer Cell-Secreted miR-33a Reduces Stress Granule Formation by Targeting Polyamine Metabolism in Stroma to Promote Tumourigenesis

Journal of Extracellular Vesicles

​

 

2026.03.24

Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung

Cancer Discovery

​

 

2026.03.17

N6-adenosine methylation enhances nuclear mRNA export through METTL3 and NUP93

Nature Cell Biology

​

 

2026.03.10

Targeting thymine DNA glycosylase induces synthetic lethality in p53-deficient cancers

Nature Chemical Biology

​

 

2026.03.04

METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers

Nature Cancer

 

2026.02.09

Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit-and-run” paradigm

Cancer Communications

 

2026.02.02

Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality

Nature Communications

 

2026.01.27

Single-molecule m6A detection empowered by endogenous labeling unveils complexities across RNA isoforms

Molecular Cell

 

2026.01.20

METTL3-dependent m6A RNA methylation regulates transposable elements and represses human naïve pluripotency through transposable element-derived enhancers

Nucleic Acids Research

 

2026.01.13

Nuclear m6A modification regulates satellite transcription and chromosome segregation

Nature Chemical Biology

 

2026.01.07

FOCAS: Transcriptome-wide screening of individual m6A sites functionally dissects epitranscriptomic control of gene expression in cancer

Cell

2025. 12. 30

Isoform characterization of m6A in single cells identifies its role in RNA surveillance

Nature Commuications

​

2025. 12. 17

LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradation

Journal of Experimental & Clinical Cancer Research

​

2025. 12. 09

Targeting the ESCRT-III component CHMP2A for noncanonical Caspase-8 activation on autophagosomal membranes

Cell Death & Differentiation

​

2025. 11. 30

Synthetic lethality of mRNA quality control complexes in cancer

Nature

​

2025. 11. 11

SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification

Cancer Research

​

2025. 11. 05

METTL14 Enhances Antitumor Immunity throughm6A-Dependent Loss of PD-1

Cancer Research

​

2025. 10. 21

YTHDF proteins and m 6 A-RNA clients undergo autophagic turnover during contact inhibition

Cell Reports

​

2025. 09. 23

Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma

Journal of Nanobiotechnology 

​

2025. 09. 16

SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation

Cell Stem Cell

​

2025. 09. 02

Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy

Nature Immunology

​

2025. 08. 05

TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells

Cell Death & Discovery

​

2025. 07. 30

Nuclear accumulation of YTHDF1 regulates mRNA splicing in the DNA damage response

Science Advances

​

2025. 07. 22

SWI/SNF as mechanoregulated inhibitor of YAP/TAZ

Nature

​

2025. 07. 15

A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets

Nature Cancer

​

2025. 07. 01

tRNA modifications tune m6A-dependent mRNA decay

Cell

​

2025. 06. 24

The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance

Molecular Cell

​

2025. 06. 17

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway

Cancer Letters

​

2025. 06. 10

m6A alters ribosome dynamics to initiate mRNA degradation

Cell

​

2025. 05. 27

Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14

Science Advances

​

2025. 05. 19

Suppression of stress granule formation is a vulnerability imposed by mutant p53

Nature Commuications

​

2025. 04. 20

Poly-(ADP-ribose) serves as a scaffold for the methyltransferase METTL3 / 14 complex in the DNA damage response

Nucleic Acids Research

​

2025. 04. 09

Spatial control of m6A deposition on enhancer andpromoter RNAs through co-acetylation of METTL3and H3K27 on chromatin

Molecular Cell

​

2025. 04. 01

The coevolution of the genome and epigenome in colorectal cancer

Nature

​

2025. 03. 24

IGF2BP3 promotes mRNA degradation through internal m7G modification

Nature Commuications

​

2025. 03. 17

METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer

Redox Biology

​

2025. 03. 11

The RNA m6A Reader YTHDF2 MaintainsOncogene Expression and Is a TargetableDependency in Glioblastoma Stem Cells

Cancer Discovery

​

2025. 03. 04

Synonymous mutations promote tumorigenesis bydisrupting m6A-dependent mRNA metabolism

Cell

​

2025. 02. 11

Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis

Cell Death & Differentiation

​

2025. 02. 25

Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation

Cell

​

2025. 02. 18

Single-nucleus multiomic mapping of m6A methylomes and transcriptomes in native populations of cells with sn-m6A-CT

Molecular Cell

​

2025. 02. 04

ATXN2-mediated translation of TNFR1promotes esophageal squamous cellcarcinoma via m6A-dependent manner

Molecular Therapy

​

2025. 01. 21

Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer

Cancer Discovery
 

2025. 01. 14

Intrinsically disordered region-mediated condensation of IFN-inducible SCOTIN_SHISA-5 inhibits ER-to-Golgi vesicle transport

Developmental Cell

​

2025. 01. 06

QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism

Cell

​

2024. 12. 31

Nuclear retention coupled with sequential polyadenylation dictates post-transcriptional m6A modification in the nucleus

Molecular Cell

​

2024. 12. 24

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells

Cancer Discovery

​

2024. 12. 17

m6A sites in the coding region trigger translation-dependent mRNA decay

Molecular Cell

​

2024. 12. 10

DNA damage induces p53-independent apoptosis through ribosome stalling

Science

​

2024. 12. 04

STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma

Cancer Cell

​

2024. 11. 19

The N6-methyladenosine epitranscriptomic landscape of lung adenocarcinoma

Cancer Discovery

​

2024. 11. 05

m6A-modified cenRNA stabilizes CENPA to ensure centromere integrity in cancer cells

Cell

​

2024. 10. 29

Inhibition of the MYC-regulated glutaminase metabolic axis is an effective synthetic lethal approach for treating chemoresistant OC

Cancer Research

​

2024. 10. 22

DNA damage promotes TMPRSS2-ERG oncoprotein destruction and prostate cancer suppression via signaling converged by GSK3b and WEE1

Molecular Cell

​

2024. 10. 15

BNIP3 phosphorylation by JNK1/2 promotes mitophagy via enhancing its stability under hypoxia

Cell Death & Disease

​

2024. 09. 24

m6A-dependent glycolysis enhances colorectal cancer progression

Molecular Cell

​

2024. 08. 13

METTL1/WDR4-mediated tRNA m7G modification and mRNA translation control promote oncogenesis and doxorubicin resistance

Oncogene

​

2024. 07. 30

HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling

Redox Biology

​

2024. 07. 23

A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling

Molecular Cell

​

2024. 07. 16

m6A governs length-dependent enrichment of mRNAs in stress granules

Nature Structural & Molecular Biology

​

2024. 07. 02

The tumor-intrinsic role of the m6A reader YTHDF2 in regulating immune evasion

Science Immunology

​

2024. 06. 25

Prediction of m6A and m6C at single-molecule resolution reveals a transcriptome-wide co-occurrence of RNA modifications

Nature  Communications

​

2024. 05. 21

Single-molecule epitranscriptomic analysis of full-length HIV-1 RNAs reveals functional roles of site-specific m6As

Nature Microbiology 

​

2024. 05. 07

Structural and functional properties of mSWI/SNF chromatin remodeling complexes revealed through single-cell perturbation screens

Molecular Cell

​

2024. 04. 30

Low RNA stability signifies increased post-transcriptional regulation of cell identity genes

Nucleic Acids Research

​

2024. 04. 24

Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis

The Journal of Clinical Investigation

​

2024. 04. 16

DDX21 mediates co-transcriptional RNA m6A modification to promote transcription termination and genome stability

Molecular Cell

​

2024. 04. 09

A circular RNA activated by TGFb promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability

Nature  Communications

​

2024. 04. 02

Transcriptional control of leukemogenesis by the chromatin reader SGF29

Blood

​

2024. 03. 26

METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

Nucleic Acids Research

​

2024. 03. 20

Targeting NURP1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors

EMBO Molecular Medicine

​

2024. 03. 13

The ARID1A-METTL3-m6A axis ensures effective RNase H1-mediated resolution of R-loops and genome stability

Cell Reports

​

2024. 03. 05

PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to control cancer cell radiosensitivity

Molecular Therapy

​

2024. 02. 27

A deregulated m6A writer complex axis driven by BRD4 confers and epitranscriptomic vulnerability in combined DNA repair-targeted therapy

PNAS

​

2024. 02. 20

Receptor-driven ERK pulses reconfigure MAPK signaling and enable persistence of drug-adapted BRAF-mutant melanoma cells

Cell Systems

​

2024. 02. 13

YTHDF2 is a therapeutic target for HCC by suppressing immune evasion and angiogenesis through ETV5/PD-L1/VEGFA axis

Advanced Science

​

2024. 02. 06

The chromatin remodeler CHD6 promotes colorectal cancer development by regulating TMEM65-mediated mitochondrial dynamics via EGF and Wnt signaling

Cell Discovery

​

2024. 01. 30

EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma

Molecular Cell

​

2024. 01. 23

Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma

Nature  Communications

​

2024. 01. 08

Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma

Nature Genetics

​

2024. 01. 02

Cooperation of chromatin remodeling SWI/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes

Nature Structural & Molecular Biology

​

2023. 12. 18

m6A modification negatively regulates translation by switching mRNA from polysome to P-body via IGF2BP3

Molecular Cell

​

2023. 12. 11

p53 wild-type colorectal cancer cells that expres a fetal gene signature are associated with metastasis and poor prognosis

Nature  Communications

​

2023. 12. 04

Targeting glutamine metabolism slows soft tissue sarcoma growth

Nature  Communications

​

2023. 11. 27

Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12

Nature  Communications

​

2023. 11. 13

Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling

Science

​

2023. 10. 30

Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation

Nature Communications

​

2023. 10. 23

CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes

Nature Communications

​

2023. 10. 16

METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity

Protein & Cell

​

2023. 09. 25

RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation

Nature Cell Biology

​

2023. 09. 18

METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer

Cell Death & Differentiation

​​

2023. 09. 11

N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2

Cell Death & Differentiation

​​

2023. 08. 30

Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity

Cancer Discovery

​​​

2023.08.23

The m6A reader IMP2 directs autoimmune inflammation through an IL-17– and TNF-dependent C/EBP transcription factor axis

Science Immunology

​​

2023.08.16

Targeting Anthrax Toxin Receptor 2 Ameliorates Endometriosis Progression

Theranostics

​​

2023.08.09

The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer

The Journal of Clinical Investigation

​​

2023.08.02

GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway

Cellular Signaling

​​

2023.07.18

Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis

Cancer Cell

​

2023.07.05

METTL14 regulates chromatin bivalent domains in mouse embryonic stem cells

Cell Reports

​

2023.06.27

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy

Cancer Cell

​

Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation

Nature Communications

​

RBM33 is a unique m6 A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity

Molecular Cell

​

Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation

Cancer Discovery

​

Neddylation is essential for b-catenin degradation in Wnt signaling pathway

Cell Reports

​

Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer

Cancer Discovery

​

2023.04.05

A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin

Immunity

​

2023.03.28

METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis

EMBO Rep

​

2023. 03. 14

Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer

Gut

​

2023. 03. 08

Exon architecture controls mRNA m6A suppression and gene expression

Science

​

2023. 02. 27

Single-molecule identification of the target RNAs of different RNA binding proteins simultaneously in cells

Genes & Development

​

2023. 02. 14

Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis

Cell Reports

​

2023. 02. 08

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

Science Advances

​

2023. 01. 31

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer

Journal of Hematology & Oncology

​

2023. 01. 18

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients

Nature Communications

​

2023. 01. 10

The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity

Nature Communications

​

2023. 01. 04

A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation

Nature Cell Biology

2022. 12. 27

CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint

Nature Communications

​

2022. 12. 20

Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PAR

Journal of Hematology & Oncology

​

2022. 11. 29

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

Nature Communications

​

2022. 11. 22

METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions

Nature Communications

​

2022. 11. 15

Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI

Nature Protocols

​

2022. 11. 01

RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways

Nature Communications

​

20220. 10. 25

Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA

Nature Communications

​

2022. 10. 18

Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain

Cell

​

2022. 10. 11

RNA m6A regulates transcription via DNA demethylation and chromatin accessibility

Nature  Genetics

​

2022. 10. 04

Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts

Gut

​

2022. 09. 27

Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control

Nature

​

2022. 09. 20

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells

Cancer Cell

​

2022. 09. 06

METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer

Gastroenterology

​

2022. 08. 31

Cell–matrix interface regulates dormancy in human colon cancer stem cells

Nature

​

2022. 08. 23

Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3

Cancer Research

​

2022. 08. 09

METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma

EBioMedicine

​

2022. 08. 02

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer

Molecular Cancer

​

2022. 07. 26

Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage

Oncogene

​

2022. 07. 12

PDGF signaling inhibits mitophagy in glioblastomastem cells through N6-methyladenosine

Dev Cell

​

2022. 07. 04

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

Nature Communications

​

2022. 06. 28

The Mettl3 epitranscriptomic writer amplifies p53 stress responses

Molecular Cell

​

2022. 06. 15

Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells

Molecular Cell

​

2022. 05. 31

A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer"

Sci Adv

​

2022. 03. 17

JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA

Cancer Research

​

2022. 05. 10

Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis

Nature Communications

​

2022. 05. 02

MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy

Cancer Research

​

2022. 04. 26

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

Nature Communications

​

2022. 04. 12

Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells

Journal for ImmunoTherapy of Cancer

​

2022. 04. 04

Integrative clinical and molecular characterization of translocation renal cell carcinoma

Cell Reports

​

2022. 03. 22

Characterization of Hippo Pathway Components by Gene Inactivation

Molecular Cell

​

2022. 02. 15

ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness

Cell Death & Differentiation

​

2022. 02. 08

Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency

Nature Communications

​

2022. 01. 25

ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis

Cell Death & Disease

​

2022. 01. 11

Regulation of AR mRNA translation in response to acute AR pathway inhibition

Nucleic Acids Res

​

2022. 01. 04

METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells

Nat Commun

​

2021. 12. 29

HRD1-mediated METTL14 degradation regulates m6A mRNA modification to suppress ER proteotoxic liver disease

Mol Cell

​

2021. 12. 13

Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer

Cancer Discov

​

2021. 12. 06

The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis

Leukemia

​

2021. 11. 29

N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer

J Hematol Oncol

​

2021. 11. 15

Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer

Cancer Cell

​

2021. 11. 09

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

Cancer Cell

​

2021. 11. 02

N6 -methyladenosine-Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression

Cancer Research

​

2021. 10. 19

N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells

Redox Biology

​​

2021. 10. 12

Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis

Cancer Cell

​​

2021. 10. 05

Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer

Science Advances

​​

2021. 09. 27

Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors

Nature Cancer

​​

2021. 09. 14

Enhancement of E-cadherin expression and processing and driving of cancer cell metastasis by ARID1A deficiency

Oncogene

​​

2021. 09. 06

mTORC stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis

Molecular Cell

©2021 by LPMO

bottom of page